Struggling to find Ebglyss (Lebrikizumab) in 2026? Learn why this atopic dermatitis biologic is hard to find and what you can do to get it.
You finally got the prescription you've been waiting for — Ebglyss (Lebrikizumab-lbkz) — and now your pharmacy is telling you they don't have it in stock. If that sounds familiar, you're not alone. Thousands of patients with moderate-to-severe atopic dermatitis are running into the same frustrating roadblock in 2026.
Ebglyss is one of the newest biologic treatments for eczema, and its limited availability has left many patients scrambling. In this article, we'll explain exactly why Ebglyss is so hard to find and what steps you can take to get your medication.
Ebglyss is the brand name for Lebrikizumab-lbkz, a biologic medication made by Eli Lilly and Company. It was approved by the FDA in September 2024 for the treatment of moderate-to-severe atopic dermatitis (eczema) in adults and adolescents aged 12 and older who weigh at least 40 kg (88 pounds).
Ebglyss works by blocking interleukin-13 (IL-13), a protein in your body that plays a major role in the inflammation, itching, and skin barrier damage that comes with eczema. It's given as a subcutaneous injection — either with a prefilled syringe or a prefilled pen — that you can administer at home after your first dose.
For more details on how the drug works, check out our guide on how Ebglyss works.
There are several reasons why finding Ebglyss in stock has been a challenge for patients in 2026. Here are the main factors:
Ebglyss was only approved in September 2024, making it one of the newest biologics on the market. Unlike common medications that every pharmacy carries, biologics like Ebglyss require special storage (refrigeration) and are typically only available through specialty pharmacies. Most retail pharmacies — including your local CVS, Walgreens, or Walmart — don't stock it on their shelves.
Because Ebglyss is a biologic, it's distributed through a limited network of specialty pharmacies. These pharmacies are equipped to handle the cold-chain shipping and patient support services that biologics require. However, this also means you can't simply walk into any pharmacy and pick it up. Your prescription often needs to be transferred to an approved specialty pharmacy, which can add days or even weeks to the process.
Even if a specialty pharmacy has Ebglyss in stock, insurance companies often require prior authorization before they'll cover it. Many plans also require step therapy, meaning you may need to show that you've tried and failed other treatments — such as topical corticosteroids or even alternative biologics like Dupixent — before your insurer will approve Ebglyss. These approval processes can take days to weeks, making the wait feel even longer.
Ebglyss had a delayed path to market. The FDA initially declined to approve it in September 2023 due to issues found during a manufacturing facility inspection — not because of safety or clinical concerns. The drug wasn't finally approved until a full year later in September 2024. This delayed launch means that production and distribution networks are still ramping up compared to more established competitors.
The good news is that there are steps you can take right now to improve your chances of getting Ebglyss:
Medfinder helps you search for Ebglyss availability at pharmacies near you in real time. Instead of calling pharmacy after pharmacy, you can check stock in seconds. It's free to use and can save you hours of frustration.
Your dermatologist's office likely works with one or more specialty pharmacies that carry Ebglyss. Ask them to send your prescription directly to a specialty pharmacy that has confirmed stock. Many specialty pharmacies also offer home delivery, which can be more convenient than picking up in person.
Don't wait until your current treatment runs out to begin the insurance approval process. Ask your doctor to submit the prior authorization as soon as possible. Having your insurance pre-approval in place before you need the medication can prevent gaps in treatment.
If cost or insurance coverage is part of the problem, Eli Lilly offers an Ebglyss Savings Card for commercially insured patients, potentially reducing your out-of-pocket cost to as little as $0 per injection. For uninsured or underinsured patients, the Lilly Cares Foundation patient assistance program may provide the medication at no cost. Learn more in our article on how to save money on Ebglyss.
Finding Ebglyss in 2026 can be challenging, but it's not impossible. The biggest hurdles — specialty pharmacy distribution, insurance prior authorization, and the drug's recent launch — are obstacles that patients can work around with the right strategy.
Start by using Medfinder to check availability near you, work with your dermatologist's office to navigate the specialty pharmacy process, and get your insurance paperwork started early. With a little planning and persistence, you can get the treatment your skin needs.
For more tips on locating this medication, read our guide on how to find Ebglyss in stock near you.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
